Future studies with extended follow-up periods are needed to assess the durability of the treatment response and monitor for any adverse outcomes, such as gastrointestinal disturbances, bleeding disorders, or allergic reactions, associated with EPO and vitamin E supplementation. The gene discussed is EPO; the disease is allergic disease.